Dr. Delese Mimi Darko, the Chief Executive Officer of the Food and Drugs Authority (FDA), has been appointed as the first Director-General of the African Medicines Agency (AMA).
Her appointment marks a major milestone in Africa’s quest to strengthen the regulation of medical products across the continent.
With a distinguished track record in regulatory excellence, Dr. Darko brings decades of experience to the newly established continental body.
Under her leadership, the Ghana FDA gained global recognition for its robust regulatory framework and commitment to safeguarding public health. Her expertise is expected to play a critical role in shaping the AMA’s mission to ensure access to safe, quality, and effective medical products throughout Africa.
Dr. Darko’s appointment is being hailed as a bold step toward harmonising regulatory systems, improving access to essential medicines, and promoting pharmaceutical innovation across the continent.
Her leadership is also expected to help strengthen the capacity of African regulatory authorities, bridge gaps in health equity, and accelerate efforts to combat counterfeit and substandard medical products.
The AMA, headquartered in Rwanda, was established to coordinate and enhance the regulatory landscape across African Union member states.
With Dr. Darko at the helm, stakeholders state the agency is poised to transform public health outcomes and support the development of a sustainable and resilient pharmaceutical sector in Africa.
Only 42 ambulances serving Greater Accra — Dispatch Head reveals
